Eric Luk, MD
Dr. Eric Luk is a medical oncologist treating patients at the Messino Cancer Center in Asheville, North Carolina. He specializes in the treatment of aggressive thoracic malignancies, including malignant pleural mesothelioma, as well as head and neck cancers.
In creating treatment plans, Dr. Luk takes advantage of innovative technologies and protocols to deliver the best possible outcomes for his patients. His approach to care is personal: “I focus on patient-centered care first and foremost, finding ways to improve my patients’ quality of life. By educating my patients on their diagnoses and offering insights into recommended therapies, I can help them make more informed health decisions.”[1]
Education and Career
Dr. Luk earned his medical degree at Tulane University School of Medicine in New Orleans, Louisiana, and then completed his internship and residency in Internal Medicine at the University of Massachusetts Chan Medical School in Worcester, Massachusetts. He completed his medical education and training with a fellowship in Hematology and Oncology at Ochsner Health in New Orleans. He joined Messino Cancer Center in March of 2023.[1]
Research
Dr. Luk’s research centers on improving outcomes for patients diagnosed with aggressive cancers, including malignant pleural mesothelioma and other thoracic malignancies. He received a grant in 2020 for his work investigating food insecurity among cancer patients.[1]
Dr. Luk’s recent publications include:
- Multi-Institutional Patterns of Use of Tumor-Treating Fields for Patients with Malignant Pleural Mesothelioma.Tugce Kutuk, Joshua M Walker, Matthew T Ballo, Robert B Cameron, Jean Bustamante Alvarez, Sheema Chawla, Eric Luk, Deepti Behl, Alan Dal Pra, Neil Morganstein, Arshin …>; Current Oncology. 2023 May 23[2]
- Malignant Mesothelioma and Germline Heterozygous BAP1 Mutation in a Young Woman Presenting with Recurrent Pleural Effusions and Worsening Pneumothorax after Talc Pleurodesis. Luk, E. & Kute, B. CHEST. 2020, October 1. [3]
- Alternative Digit Ratios and Their Relationship to Prostate Cancer.Michael Stolten, Elisa Ledet, Ary Dotiwala, Eric Luk, Oliver Sartor>; Clinical Genitourinary Cancer. 2016 Apr 1[2]
- Characterizations of Clinical and Therapeutic Histories for Men With Prostate Cancer-Specific Mortality.Allie E. Steinberger, Elisa Ledet, Eric Luk, Patrick Cotogno, Michael Stolten, Daniel Desmond, Allison H. Feibus, Jonathan L. Silberstein, Oliver Sartor>; Clinical Genitourinary Cancer. 2016 Apr 1[2]
